Antimicrobial Resistance - Breakthrough Innovation and Breaking Barriers Webinar
Nathalie Ma, Co-founder & Head of Business Development, Felix Biotechnology Richard Alm, Alliance Director, CARB-X Mark McClellan, Director and Robert J. Margolis, MD, Professor of Business, Medicine and Policy, Margolis Center for Health Policy at Duke U
Johnson & Johnson Innovation Event
Topics include:
Priority MDR bacterial pathogens of interest
Potential interventions to prevent and treat MDR bacterial infections
Barriers in the development and commercialization pathway
The need for policy change to address these barriers
The potential roles of various organizations and public-private partnerships
Click here for more information and registration details